HCG inks pact with Apex Criticare, Niruja, Apex HCG

03 Aug 2018 Evaluate

HealthCare Global Enterprises (HCG) has entered into a Deed of Admission and Retirement of Partner with Apex Criticare LLP (Apex Criticare), Niruja Product Development and Healthcare Research (Niruja) and Apex HCG Oncology Hospitals LLP (the LLP), on August 01, 2018, with respect to the retirement/exit of Apex Criticare as a partner in the LLP, and the consequent induction of Niruja as a new partner in the LLP.

On and from the execution date, Apex Criticare has exited from the LLP as a partner. The partners of the LLP from the Execution Date are HCG and Niruja, with a capital contribution in the ratio of 99.9% and 0.1%, respectively.

HCG is the largest provider of cancer care in India. Through its network of comprehensive cancer centres spread across India, HCG has brought advanced cancer care to the doorstep of millions of people.

HealthcareGlobal Share Price

498.45 -0.15 (-0.03%)
15-Jan-2025 16:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 6694.40
Max Healthcare Inst 1039.35
Narayana Hrudayalay 1287.85
Aster DM Healthcare 489.85
Global Health 1023.35
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.